Antidiabetics Market Top Players – Eli Lilly, Bayer Corporation, Novartis, Johnson & Johnson, AstraZeneca, Pfizer, Bristol-Myers Squibb, Novo Nordisk, Merck, Boehringer Ingelheim, Oramed Pharmaceuticals, Takeda Pharmaceutical and Sanofi
Inherently propelled by a stringent regulatory framework, antidiabetics market is strongly characterized by the legalized norms implemented by authorized bodies such as the European CE and the FDA. Having undertaken the crucial responsibility of regulating the commercialization of antidiabetics in clinical trials, these organizations continue to strive hard to approve drugs post their testing with utmost caution and precision, which is a prime factor driving the growth of antidiabetics industry. For instance, recently, the U.S. Food and Drug Administration approved the Bydureon BCise (exenatide extended-release) injectable suspension manufactured by AstraZeneca. Apparently, this drug is an all-new formulation of Bydureon that is available as a single-dose autoinjector device for adults suffering from Type II diabetes. The Bydureon BCise apparently underwent two clinical trials prior to obtaining the approval, thus validating the fact that antidiabetics market outlook is strictly defined by a regulatory frame of reference.
Request sample copy of this report @ https://www.gminsights.com/request-sample/detail/504
With the exponentially growing population and the prevalence of a sedentary lifestyle, a significant rise in the patient pool suffering from diabetes has been observed, which is likely to spur global antidiabetics market share. The WHO estimates that diabetes would be among the leading causes of death by 2030, which would severely strain the overall healthcare fraternity. The rising number of diabetic cases have prompted the governments across various geographies to take steps toward promoting awareness regarding this disorder. For instance, the ‘Diabetes UK’ is slated to launch one of the biggest campaigns to encourage consciousness regarding Type II diabetes. The program will also make people aware of the harmful consequences of developing diabetes, encourage them to get screened regularly, and provide other related details. The prevalence of campaigns and awareness programs such as the aforementioned are certain to bring about a positive influence on antidiabetics market size, which was pegged at USD 49.5 billion in 2016.
In consequence to the unmet medical requirements of the healthcare fraternity and the rapid increase in the diabetic patient base, antidiabetics industry players have been concentrating on increasing their funding on research & development activities with an aim to launch novel insulin products that will efficiently treat this persistent sugar disorder. Major companies such as Sanofi Aventis, Eli Lilly, and Novo Nordisk presently predominate antidiabetic market share, pertaining to their popular brand value, wide range of products, and increased R&D investments. Many antidiabetics products that are currently in the pipeline to be commercialized are manufactured by these companies. In addition, global antidiabetics industry involves the participation of other generic manufacturers such as Pfizer, Oramed Pharmaceuticals, Inc., Takeda Pharmaceuticals, Boehringer Ingelheim, and Merck & Co. Inc.
Make Inquiry about this report @ https://www.gminsights.com/inquiry-before-buying/504
The Asia Pacific region has been forecast to emerge as the potential hotbed for investors emptying their coffers in antidiabetics industry. This estimation may be attributed to the fact that the region has been witnessing a tremendous surge in the patient pool suffering from diabetes, especially in India and China. As per reliable statistics, close to nearly two decades earlier, in 2000, India stood at the top of the pyramid representing diabetes sufferers, with more than 31.7 million of its populace afflicted by the disease, while China stood at the second place with 20.8 million diabetic patients in tow. It has been forecast that by 2030, this number would increase up to 79.4 million patients in India and 42.3 million individuals in China. The estimates stand to validate that these countries would prove to be lucrative grounds for companies partaking in antidiabetics market share, as they would be able to bring forth a range of medications for treating the affliction in these regions.
Another emerging region in this continent has been touted to be Japan. The country, with its incredible healthcare infrastructure, rising penetration of technologically innovative insulin drugs, and the growing prevalence of diabetes among the geriatric populace, will serve to be a profitable growth avenue for APAC antidiabetics market.
Regulatory and governmental bodies across the globe have been striving to increase public awareness regarding diabetes, which most certainly would provide an impetus to antidiabetics market. For instance, the National Institute of Diabetes and Digestive and Kidney Diseases has undertaken several education campaigns such as ‘Small Steps, Big Rewards’, ‘Control your Diabetes for Life’, etc., to increase the importance of diabetic screening, diagnosis, and treatment. Not far behind in the list of organizations is the American Diabetes Association, that has also launched several awareness programs regarding diabetes, which would help carve out a lucrative growth path for global antidiabetics market over the years ahead. In addition, the International Diabetes Federation, along with its member associations celebrate the 14th of November as ‘World Diabetes Day’, utilizing the 24-hour span to initiate awareness campaigns and other related programs. With a strong regulatory framework and governmental support in place, not to mention, the pivotal developments underlining the medical research and healthcare verticals, it is forecast that antidiabetics industry will chart a profitable growth curve over the coming seven years, with an estimated valuation of USD 110 billion by 2024.
Chapter 1. Methodology
1.2. Market definitions
1.3. Forecast parameters
1.4. Data sources
18.104.22.168. Paid sources
22.214.171.124. Unpaid sources
Chapter 2. Executive Summary
2.1. Antidiabetics industry 3600 synopsis, 2013 – 2024 (USD Million)
2.1.1. Business trends
2.1.2. Product trends
2.1.3. Patient population trends
2.1.4. Route of administration trends
2.1.5. Regional trends
Chapter 3. Antidiabetics Industry Insights
3.1. Industry segmentation
3.2. Industry landscape, 2013 - 2024
3.3. Industry impact forces
3.3.1. Growth drivers
126.96.36.199. Strong product pipeline of antidiabetics
188.8.131.52. Globally rising prevalence of diabetes
184.108.40.206. Increasing prevalence of lifestyle induced disorders such as obesity
3.3.2. Industry pitfalls and challenges
220.127.116.11. Prohibitive cost of insulin
3.4. Regulatory landscape
3.5. Clinical workflow analysis
3.6. Reimbursement scenario
3.7. Growth potential analysis
3.7.1. By product
3.7.2. By patient population
3.7.3. By route of administration
3.8. Porter’s analysis
3.9. Competitive landscape
3.9.1. Company market share analysis, 2017
3.9.2. Strategy dashboard
3.10. PESTEL analysis
3.11. Pipeline overview, 2018
Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.
Corporate Sales, USA
Global Market Insights, Inc.
Toll Free: 1-888-689-0688
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Antidiabetics Market Top Players – Eli Lilly, Bayer Corporation, Novartis, Johnson & Johnson, AstraZeneca, Pfizer, Bristol-Myers Squibb, Novo Nordisk, Merck, Boehringer Ingelheim, Oramed Pharmaceuticals, Takeda Pharmaceutical and Sanofi here
News-ID: 1362288 • Views: 485
More Releases from Global Market Insights, Inc.
Ethylene Propylene Diene Monomer Market will generate admirable revenue by 2024
Europe ethylene propylene diene monomer (EPDM) market is predicted to record significant gains over the coming timeframe. The increasing demand for EPDM across the construction sector will stimulate the UK EPDM industry trends, which is predicted to exhibit a CAGR of more than 4% over the coming years of 2016 to 2024. North America EPDM industry worth USD 600 million in 2015, will register a considerable growth over the coming years.
Healthcare PMMA Market Future Challenges and Industry Growth Outlook 2024
U.S. Healthcare PMMA Market led the industry demand for North America. It was evaluated at more than $48.1 million for 2015. Large aging population in U.S. along with strict FDA (Food and Drug Administration) rules to reduce use of harmful plastics in medical sector is predicted to favorably influence industry expansion. Europe Healthcare PMMA Market, dominated by Italy, UK, France, Spain and Germany, is anticipated to record CAGR of about 5%
Natural Gas Liquids Market Share to grow at 7% CAGR by 2025
Japan NGL market is set to exceed the consumption of 0.2 mbl/day by 2025. Growing demand for high value-added manufactured petrochemicals coupled with accelerating investments toward chemical industry will propel the industry growth. Furthermore, rapidly expanding various industrial bases including refineries, chemicals and manufacturing industries along with ongoing funding toward automotive sector will encourage the product penetration. Get sample copy of this research report @https://www.gminsights.com/request-sample/detail/3270 Reduced emissions from industries, lower electricity costs,
Oil Pipeline Infrastructure Market Share By Industry Growth, Trend and Forecast …
Global Market Insights added a new report on global Oil Pipeline Infrastructure Market to its research database. The report focuses on global major leading players with information such as company profiles, growth, product segment, technology segment, end user segment and region. The U.S. oil pipeline infrastructure market size will surpass the cumulative installation of 450,000 km in 2018. Upgradation of drilling technologies coupled with robust investment in infrastructure development will stimulate
More Releases for Industry
Global Trauma Product Industry
Global Trauma Product Industry Market Insights: The Global Trauma Products market is expected to grow at a CAGR of 7.2% during 2017-2022. The products that are used for the physical injuries and wounds caused by the external sources are known as trauma products. Traumatic injuries sometimes lead to long term complications such as long-term disability, chronic pain and infections and so on. It includes the injuries causing severe damage to the body
Global Nutraceuticals Market By Application | Food Industry, Ink Industry, Medic …
Researchmoz added Most up-to-date research on "Global Nutraceuticals Market By Application | Food Industry, Ink Industry, Medicine Industry, Electronic Industry and Paint Industry" to its huge collection of research reports. This report studies Nutraceuticals in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. This report focuses on top manufacturers
Global Sport Jackets Industry
Global Sport Jackets Industry Latest Report on Sport Jackets Market Global Analysis & 2022 Forecast Research Study In this report, the global Sport Jackets market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Global Sport Jackets market competition by top manufacturers, with production, price, revenue (value) and market share for
Dish Washer Industry
In our aim to bring the best and complete information to our clients, we at Orbis Research present the 2017 Global Dish Washer Market market professional survey. The well curated survey by the leading research experts and domain knowledge professionals provides clients with the true picture of the Global Dish Washer Market. The survey is expected to push the understanding of the market and its trends for the clients and
Neurorehabilitation Devices Industry Drivers
Neurorehabilitation Devices Market: Snapshot The market for neurorehabilitation devices holds a lot of potential, analysts have found. Already well-established markets in North America and Europe, coupled with immense growth opportunities in the emerging economies of Asia Pacific and Latin America indicate the favorable pace at which the global neurorehabilitation devices market is likely to grow over the coming years. The introduction of wearable technology and robotics has been having a tremendous
Global Table Lamps Industry
In our aim to provide our erudite clients with the best research material with absolute in-depth information of the market, our new report on Global Table Lamps Market is confident in meeting their needs and expectations. The 2017 market research report on Global Table Lamps Market is an in-depth study and analysis of the market by our industry experts with unparalleled domain knowledge. The report will shed light on many